AKAP12 and posterior cortical atrophy: TCGA analysis illustrated that DFS and OS of patients with high AKAP12 levels was significantly lower than patients with low AKAP12 levels (Figure S1E,F, P < .05), indicating the prognostic value of AKAP12 in clinical application for PCa.